Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Remibrutinib's trials
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
Remibrutinib
Ongoing
Recruiting
Phase 3
Open NCT07768371 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT07768371 · Trial Tracker · ComplyRx
